Clinical Trials for Carcinoid Tumor

Find clinical trials for carcinoid tumor. Discover research opportunities and treatment options in your area.

7 Active Trials Found

Showing 7 trials on this page

Page 1 of 1

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

NCT ID: NCT02628067

This clinical trial is studying a medication called pembrolizumab (MK-3475) for people with advanced solid tumors that have not responded to standard treatments. The trial aims to see how well this...

Recruiting

Phase: PHASE2 Type: interventional Locations: North Ryde, , Australia, Midrand, , South Africa +29 more

Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors

NCT ID: NCT05636618

This clinical trial is testing a new treatment called \[212Pb\]VMT-α-NET, which uses targeted alpha-particle therapy for patients with advanced neuroendocrine tumors (NETs) that express a specific ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States, Columbus, Ohio, United States +12 more

Study of RYZ101 Compared with SOC in Pts W Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

NCT ID: NCT05477576

This clinical trial is investigating a new treatment called RYZ101 for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that cannot be surgically removed and have wors...

Recruiting

Phase: PHASE3 Type: interventional Locations: Philadelphia, Pennsylvania, United States, Palo Alto, California, United States +110 more

IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers

NCT ID: NCT06790706

The IMMUNORARE5 trial is a research study that aims to evaluate a new combination of immunotherapy drugs, Domvanalimab and Zimberelimab, to see if they can help patients with five types of advanced...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Angers, , France, Bordeaux, , France +13 more

Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors

NCT ID: NCT05263050

This clinical trial is studying a new way to give cabozantinib, a medication used to treat certain types of cancer, specifically metastatic renal cell carcinoma (a type of kidney cancer that has sp...

Recruiting

Phase: PHASE2 Type: interventional Locations: Philadelphia, Pennsylvania, United States

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

NCT ID: NCT04907643

This clinical trial is exploring how virtual reality (VR) can help manage severe abdominal pain in patients with digestive tract cancers. The study aims to find out if using immersive VR—where pati...

Recruiting

Phase: NA Type: interventional Locations: Los Angeles, California, United States

SwissNET - a Registry for Neuroendocrine Tumours in Switzerland

NCT ID: NCT01039922

The SwissNET study is focused on understanding a rare type of cancer known as gastroentero-pancreatic neuroendocrine tumors (GEP-NETs), which can develop in the gastrointestinal tract and pancreas....

Recruiting

Type: observational Locations: Basel, , Switzerland, St. Gallen, , Switzerland +53 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions